Moors & Cabot, Inc. Novo Nordisk A S Transaction History

Moors & Cabot, Inc.

$1.96 Billion
Q3 2024

A detailed history of Moors & Cabot, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Moors & Cabot, Inc. holds 6,992 shares of NVO stock, worth $610,891. This represents 0.04% of its overall portfolio holdings.

Number of Shares

6,992

Previous 6,982 0.14%

Holding current value

$610,891

Previous $996,000 16.47%

% of portfolio

0.04%

Previous 0.05%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$119.07 - $145.42 $1,190 - $1,454	10 Added 0.14%	6,992 $832,000
Q2 2024 Aug 09, 2024	SELL	$122.71 - $146.91 $7,976 - $9,549	-65 Reduced 0.92%	6,982 $996,000
Q1 2024 May 08, 2024	BUY	$102.11 - $135.92 $163,376 - $217,471	1,600 Added 29.37%	7,047 $904,000
Q4 2023 Feb 14, 2024	SELL	$87.78 - $105.45 $44,153 - $53,041	-503 Reduced 8.45%	5,447 $563,000
Q3 2023 Nov 07, 2023	BUY	$90.94 - $199.54 $293,736 - $644,514	3,230 Added 118.75%	5,950 $541,000
Q2 2023 Aug 09, 2023	BUY	$155.98 - $172.65 $58,180 - $64,398	373 Added 15.89%	2,720 $440,000
Q1 2023 May 04, 2023	SELL	$132.34 - $159.14 $6,617 - $7,956	-50 Reduced 2.09%	2,347 $373,000
Q4 2022 Feb 09, 2023	SELL	$102.55 - $135.33 $5,947 - $7,849	-58 Reduced 2.36%	2,397 $324,000
Q4 2022 Feb 06, 2023	SELL	$102.55 - $135.33 $14,869 - $19,622	-145 Reduced 5.58%	2,455 $332,000
Q3 2022 Nov 07, 2022	SELL	$95.28 - $116.93 $14,101 - $17,305	-148 Reduced 5.39%	2,600 $259,000
Q2 2022 Aug 08, 2022	BUY	$103.24 - $121.81 $14,660 - $17,297	142 Added 5.45%	2,748 $306,000
Q1 2022 May 13, 2022	SELL	$93.1 - $112.54 $744 - $900	-8 Reduced 0.31%	2,606 $289,000
Q4 2021 Feb 14, 2022	SELL	$95.88 - $117.08 $586,210 - $715,827	-6,114 Reduced 70.05%	2,614 $293,000
Q3 2021 Dec 08, 2021	SELL	$84.42 - $106.62 $409,943 - $517,746	-4,856 Reduced 35.75%	8,728 $836,000
Q3 2021 Nov 05, 2021	BUY	$84.42 - $106.62 $926,087 - $1.17 Million	10,970 Added 419.66%	13,584 $2.89 Million
Q2 2021 Aug 10, 2021	BUY	$67.66 - $84.76 $176,863 - $221,562	2,614 New	2,614 $219,000
Q1 2021 May 12, 2021	SELL	$67.06 - $75.82 $242,354 - $274,013	-3,614 Closed	0 $0
Q3 2020 Nov 09, 2020	SELL	$63.69 - $70.22 $3,502 - $3,862	-55 Reduced 1.5%	3,614 $251,000
Q2 2020 Aug 13, 2020	BUY	$58.54 - $67.94 $214,783 - $249,271	3,669 New	3,669 $239,000
Q1 2018 May 18, 2018	SELL	$48.49 - $58.14 $195,172 - $234,013	-4,025 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$47.53 - $53.73 $191,308 - $216,263	4,025	4,025 $216,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.

Account